全球灌注系统市场 - 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球灌注系统市场 - 行业趋势和 2029 年预测

  • Healthcare
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 页面
  • 桌子數: 60
  • 图号: 220

Global Perfusion Systems Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –0
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 60.50
Diagram CAGR
%
Diagram Major Markets Players
  • Market players covered:
  • Getinge AB
  • Medtronic PLC
  • Livanova PLC
  • Terumo Corporation

>全球灌注系统市场,按组件(心肺机、灌注泵、氧合器、监测系统、套管)、类型(生物反应器灌注系统、微流体灌注系统、重力或压力驱动灌注系统、小型哺乳动物器官灌注系统)、技术(低温机器灌注、常温机器灌注)划分 - 行业趋势和预测到 2029 年。

灌注系统市场

全球灌注系统市场分析和规模

为了通过手术治疗患有心脏和呼吸系统疾病的患者,人们使用灌注装置来绕过心肺系统。当心脏和肺部无法进行血液氧合过程时,心肺机等灌注装置会提供氧气并去除二氧化碳

  • 由于心肺衰竭的发病率不断上升,氧合器成为灌注系统市场中最大的组件部分。Data Bridge Market Research 分析称,2021 年灌注系统市场价值为 11.988 亿美元,预计到 2029 年将达到 6050 万美元,预计在 2022 年至 2029 年的预测期内,复合年增长率为 4.4%。

报告范围和市场细分                                                     

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制至 2019 - 2014)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

组件(心肺机、灌注泵、氧合器、监测系统、插管)、类型(生物反应器灌注系统、微流体灌注系统、重力或压力驱动灌注系统、小型哺乳动物器官灌注系统)、技术(低温机器灌注、常温机器灌注)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、欧洲的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Getinge AB(瑞典)、Medtronic PLC(美国)、Livanova PLC(英国)、Terumo Corporation(日本)、Nipro Corporation(日本)、Xenios AG(德国)、Repligen Corporation(美国)、Spectrum Laboratories, Inc.(美国)、Merck KGaA(德国)、Harvard Bioscience, Inc.(美国)、ALA Scientific Instruments, Inc.(美国)、Lifeline Scientific(美国)、Xvivo Perfusion AB(瑞典)、General Electricals Inc(美国)、Hitachi Ltd(日本)、Koninkliijike Philips NV(荷兰)、Samsung Electronics Co, Ltd.(韩国)、Shimadzu Corporation(日本)、Siemens(美国)、Toshiba Corporation(日本)、Accuray Incorporated(美国)、Xvivo Perfusion(瑞典)。

Market Opportunities

  • The rising frequency of cardiovascular and respiratory disorders
  • Increased government and non-governmental measures to encourage organ donation
  • Increased investment in cell-based research
  • The rising biologics manufacturing activities.

Global Perfusion Systems Market Definition

The process of providing oxygenated blood to the body's tissues is known as perfusion. Perfusion systems are commonly used in organ transplant surgeries because they assist in the replacement of the organ's function by pumping blood throughout the body.

Perfusion Systems Market Dynamics

Major factors that are expected to boost the growth of the perfusion systems market in the forecast period are as follows:

Drivers

  • Rise in the Incidence of Cardiovascular and Respiratory Diseases

Cardiovascular illnesses are one of the most common causes of death worldwide. They are responsible for over 9.4 million fatalities per year. Hypertension is becoming more common, which is a major risk factor for cardiovascular disease and stroke will further accelerate the market growth.

  • Growing Healthcare Expenditure

The market is growing due to an increase in the number of organ donors, increased healthcare spending, and favourable healthcare legislation.

  • Constant Product Advancement

In the coming years, the expanding number of system distributors and dealers is expected to strengthen market growth for perfusion systems.

Opportunities

In addition, the growing pharmaceutical research is further estimated to provide potential opportunities for the growth of the perfusion systems market in the coming years.

Restraints/Challenges Global Perfusion Systems Market

On the other hand, the increased cost of organ transplantation is further projected to impede the growth of the perfusion systems market in the targeted period. However, the organ supply-demand gap might further challenge the growth of the perfusion systems market in the near future.

This perfusion systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the perfusion systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Perfusion Systems Market

The pandemic of COVID-19 has had a huge impact on the perfusion systems market. The global COVID-19 outbreak has shifted financial resources away from healthcare and toward perfusion systems. COVID-19 also causes organ failure, making transplantation difficult. The COVID-19 outbreak has been rescheduled in most locations around the world to suit the situation and prevent patient exposure to the virus through perfusion systems. However, in the post-COVID scenario, perfusion systems market is projected to be significantly impacted.

Recent Development

  • In May 2019, Xvivo Perfusion System received FDA approval for their Steen solution perfusate system. The device lets the transplant team to perform a careful assessment of lung function to get a healthier sense of how the organs are working when they are perfused with a solution outside the body to better conclude whether the lungs can then be workable for transplant.

Global Perfusion Systems Market Scope and Market Size

The perfusion systems market is segmented on the basis of component, type and technique. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Component

  • Heart-lung Machines
  • Perfusion Pumps
  • Oxygenators
  • Monitoring Systems
  • Cannulas

On the basis of component, the perfusion systems market is segmented into heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas.

Type

  • Bioreactor Perfusion Systems
  • Microfluidic Perfusion Systems
  • Gravity or Pressure-Driven Perfusion Systems
  • Small-Mammal Organ Perfusion Systems

On the basis of type, the perfusion systems market is segmented into bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure-driven perfusion systems and small-mammal organ perfusion systems.

Technique

  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

On the basis of technique, the perfusion systems market is segmented into hypothermic machine perfusion, normothermic machine perfusion.

Perfusion Systems Market Regional Analysis/Insights

The perfusion systems market is analysed and market size insights and trends are provided by country, component, type and technique as referenced above.

The countries covered in the perfusion systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the perfusion systems market due to the rise in the demand for organ transplant and cardiothoracic surgeries. Furthermore, the several initiatives taken by the government to raise the awareness for organ donation will further boost the growth of the perfusion systems market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the perfusion systems market due to the rise in the adoption of advanced technologies. Moreover, the increasing population is further anticipated to propel the growth of the perfusion systems market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The perfusion systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for perfusion systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the perfusion systems market. The data is available for historic period 2010-2020.

Competitive Landscape and Perfusion Systems Market Share Analysis

The perfusion systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to perfusion systems market.

 Some of the major players operating in the perfusion systems market are:

  • Getinge AB (Sweden)
  • Medtronic PLC (US)
  • Livanova PLC (UK)
  • Terumo Corporation (Japan)
  • Nipro Corporation (Japan)
  • Xenios AG (Germany)
  • Repligen Corporation (US)
  • Spectrum Laboratories, Inc. (US)
  • Merck KGaA (Germany)
  • Harvard Bioscience, Inc. (US)
  • ALA Scientific Instruments, Inc. (US)
  • Lifeline Scientific (US)
  • Xvivo Perfusion AB (Sweden)
  • General Electricals Inc (US)
  • Hitachi Ltd (Japan)
  • Koninkliijike Philips N.V. (Netherlands)
  • Samsung Electronics Co, Ltd. (South Korea)
  • Shimadzu Corporation (Japan)
  • 西门子(美国)
  • 东芝公司(日本)
  • Accuray Incorporated(美国)
  • Xvivo Perfusion(瑞典)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Perfusion Systems Market size will be worth USD 60.50 million by 2029.
The Perfusion Systems Market growth rate is 4.4% by 2029.
Constant Product Advancement, Growing Healthcare Expenditure, Rise in the Incidence of Cardiovascular and Respiratory Diseases are the growth drivers of the Perfusion Systems Market.
The component, type and technique are the factors on which the Perfusion Systems Market research is based.
The major companies in the Perfusion Systems Market are Getinge AB (Sweden), Medtronic PLC (US), Livanova PLC (UK), Terumo Corporation (Japan), Nipro Corporation (Japan), Xenios AG (Germany), Repligen Corporation (US), Spectrum Laboratories, Inc. (US), Merck KGaA (Germany), Harvard Bioscience, Inc. (US), ALA Scientific Instruments, Inc. (US), Lifeline Scientific (US), Xvivo Perfusion AB (Sweden), General Electricals Inc (US), Hitachi Ltd (Japan), Koninkliijike Philips N.V. (Netherlands), Samsung Electronics Co, Ltd. (South Korea), Shimadzu Corporation (Japan), Siemens (US), Toshiba Corporation (Japan), Accuray Incorporated (US), Xvivo Perfusion (Sweden).